Lupin gets US FDA nod for sodium zirconium cyclosilicate EP News Bureau Aug 11, 2026 The drug is bioequivalent to AstraZeneca’s Lokelma and indicated for hyperkalaemia in adults
CKD-hyperparathyroidism, hyperphosphatemia, hyperkalemia market to grow at 6.9% CAGR by 2030:… EP News Bureau May 18, 2021 Historically, the CKD-HPT, HP, and HK disease space mainly consisted of reformulations of existing drugs and repurposed drugs from…
